Your browser doesn't support javascript.
loading
Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.
Lin, Xiaoyun; Chen, Shao; Xue, Xiangyang; Lu, Lijun; Zhu, Shanli; Li, Wenshu; Chen, Xiangmin; Zhong, Xiaozhi; Jiang, Pengfei; Sename, Torsoo Sophia; Zheng, Yi; Zhang, Lifang.
Afiliação
  • Lin X; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Chen S; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Xue X; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Lu L; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Zhu S; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Li W; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Chen X; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Zhong X; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Jiang P; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Sename TS; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
  • Zheng Y; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
  • Zhang L; Department of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Wenzhou Medical University, Wenzhou, China.
Cell Mol Immunol ; 13(4): 492-501, 2016 07.
Article em En | MEDLINE | ID: mdl-25864917
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Carcinoma / Proteínas da Matriz Viral / Neoplasias Nasofaríngeas / Herpesvirus Humano 4 / Vacinas Anticâncer / Epitopos Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Carcinoma / Proteínas da Matriz Viral / Neoplasias Nasofaríngeas / Herpesvirus Humano 4 / Vacinas Anticâncer / Epitopos Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China